We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
86 hedge funds and large institutions have $475M invested in Revance Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
111% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 19
14% more call options, than puts
Call options by funds: $935K | Put options by funds: $822K
17% less funds holding
Funds holding: 104 → 86 (-18)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
49% less capital invested
Capital invested by funds: $929M → $475M (-$454M)
67% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 27
Holders
86
Holders Change
-18
Holders Change %
-17.31%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
9
Increased
40
Reduced
19
Closed
27
Calls
$935K
Puts
$822K
Net Calls
+$113K
Net Calls Change
-$2.93M
